Carroll Financial Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $1.18M | Buy |
18,971
+2,143
| +13% | +$126K | 0.06% | 166 |
|
|
2021
Q3 | $995K | Sell |
16,828
-1,230
| -7% | -$81K | 0.06% | 187 |
|
|
2021
Q2 | $1.21M | Buy |
18,058
+642
| +4% | +$41.9K | 0.07% | 170 |
|
|
2021
Q1 | $1.1M | Sell |
17,416
-254
| -1% | -$15.8K | 0.07% | 163 |
|
|
2020
Q4 | $1.1M | Sell |
17,670
-583
| -3% | -$35.8K | 0.07% | 158 |
|
|
2020
Q3 | $1.1M | Sell |
18,253
-900
| -5% | -$54.2K | 0.08% | 141 |
|
|
2020
Q2 | $1.13M | Sell |
19,153
-2
| -0% | -$120 | 0.09% | 133 |
|
|
2020
Q1 | $1.07M | Buy |
19,155
+396
| +2% | +$24.2K | 0.1% | 123 |
|
|
2019
Q4 | $1.2M | Buy |
18,759
+1,146
| +7% | +$65.6K | 0.1% | 122 |
|
|
2019
Q3 | $893K | Sell |
17,613
-531
| -3% | -$25K | 0.08% | 153 |
|
|
2019
Q2 | $822K | Buy |
18,144
+411
| +2% | +$19.1K | 0.07% | 153 |
|
|
2019
Q1 | $846K | Buy |
17,733
+709
| +4% | +$35.3K | 0.08% | 139 |
|
|
2018
Q4 | $824K | Buy |
17,024
+248
| +1% | +$13.3K | 0.09% | 121 |
|
|
2018
Q3 | $1.04M | Sell |
16,776
-1,393
| -8% | -$82.7K | 0.11% | 113 |
|
|
2018
Q2 | $1M | Buy |
18,169
+766
| +4% | +$41.4K | 0.11% | 114 |
|
|
2018
Q1 | $1.1M | Sell |
17,403
-1,644
| -9% | -$106K | 0.12% | 107 |
|
|
2017
Q4 | $1.17M | Sell |
19,047
-1,496
| -7% | -$93.6K | 0.13% | 102 |
|
|
2017
Q3 | $1.31M | Buy |
20,543
+423
| +2% | +$24.7K | 0.15% | 91 |
|
|
2017
Q2 | $1.12M | Sell |
20,120
-2,196
| -10% | -$119K | 0.14% | 101 |
|
|
2017
Q1 | $1.21M | Buy |
22,316
+165
| +0.7% | +$9.05K | 0.15% | 90 |
|
|
2016
Q4 | $1.29M | Sell |
22,151
-3,310
| -13% | -$181K | 0.18% | 76 |
|
|
2016
Q3 | $1.37M | Buy |
25,461
+10,514
| +70% | +$675K | 0.21% | 73 |
|
|
2016
Q2 | $1.1M | Buy |
14,947
+419
| +3% | +$29.6K | 0.18% | 79 |
|
|
2016
Q1 | $928K | Buy |
14,528
+316
| +2% | +$19.9K | 0.17% | 83 |
|
|
2015
Q4 | $977K | Sell |
14,212
-756
| -5% | -$50K | 0.2% | 80 |
|
|
2015
Q3 | $935K | Buy |
14,968
+1,874
| +14% | +$119K | 0.21% | 78 |
|
|
2015
Q2 | $871K | Buy |
13,094
+6,050
| +86% | +$399K | 0.19% | 79 |
|
|
2015
Q1 | $454K | Buy |
7,044
+1,294
| +23% | +$81K | 0.2% | 82 |
|
|
2014
Q4 | $341K | Sell |
5,750
-5,400
| -48% | -$305K | 0.22% | 80 |
|
|
2014
Q3 | $654K | Buy |
11,150
+500
| +5% | +$25K | 0.2% | 81 |
|
|
2014
Q2 | $517K | Buy |
10,650
+1,200
| +13% | +$59.1K | 0.14% | 96 |
|
|
2014
Q1 | $491K | Sell |
9,450
-2,004
| -17% | -$107K | 0.16% | 84 |
|
|
2013
Q4 | $608K | Buy |
11,454
+320
| +3% | +$16.3K | 0.22% | 77 |
|
|
2013
Q3 | $515K | Buy |
11,134
+483
| +5% | +$21.2K | 0.19% | 77 |
|
|
2013
Q2 | $475K | Buy |
+10,651
| New | +$462K | 0.23% | 72 |
|
Other funds holding BMY
Carroll Financial Associates's BMY Position: Q4 2021 in Review
Carroll Financial Associates increased its Bristol-Myers Squibb (BMY) stake by 13% in Q4 2021, buying an estimated $126K and bringing the position to 18,971 shares worth $1.18M. The position accounts for 0.06% of the portfolio, ranked #166.
Carroll Financial Associates first reported a position in BMY in Q2 2013 and has held it in 35 quarters since. The position peaked at $1.37M in Q3 2016. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- Carroll Financial Associates held 18,971 shares of Bristol-Myers Squibb worth $1.18M as of Q4 2021.
- Carroll Financial Associates bought 2,143 Bristol-Myers Squibb shares in Q4 2021, an estimated $126K.
- Bristol-Myers Squibb made up 0.06% of Carroll Financial Associates's portfolio in Q4 2021, its #166 holding.
- Carroll Financial Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 35 quarters since.
- Carroll Financial Associates's Bristol-Myers Squibb position peaked at $1.37M in Q3 2016.
- 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.